JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB128935

Anti-BCKDK antibody [EPR7564]

5

(1 Review)

|

(7 Publications)

Rabbit Recombinant Monoclonal BCKDK antibody. Suitable for WB and reacts with Rat, Human, Mouse samples. Cited in 7 publications.

View Alternative Names

Branched-chain alpha-ketoacid dehydrogenase kinase, BCKDH kinase, BCKDHKIN, BDK, BCKDK

5 Images
Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)
  • WB

Lab

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : BCKDH kinase knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab128935 observed at 48 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab128935 was shown to specifically react with BCKDH kinase when BCKDH kinase knockout samples were used. Wild-type and BCKDH kinase knockout samples were subjected to SDS-PAGE. ab128935 and ab8245 (loading control to GAPDH) were diluted at 1/1000 and 1/10,000 dilution respectively and incubated overnight at 4C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-BCKDK antibody [EPR7564] (ab128935)

Predicted band size: 46 kDa

false

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)
  • WB

Lab

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)

All lanes:

Western blot - Anti-BCKDK antibody [EPR7564] (ab128935) at 1/1000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

Rat heart tissue lysate at 20 µg

Lane 3:

Rat kidney tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 46 kDa

Observed band size: 46 kDa

false

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)
  • WB

Lab

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)

All lanes:

Western blot - Anti-BCKDK antibody [EPR7564] (ab128935) at 1/1000 dilution

Lane 1:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 15 µg

Lane 2:

RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 46 kDa

Observed band size: 46 kDa

false

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)
  • WB

Unknown

Western blot - Anti-BCKDK antibody [EPR7564] (AB128935)

All lanes:

Western blot - Anti-BCKDK antibody [EPR7564] (ab128935) at 1/1000 dilution

Lane 1:

Fetal kidney lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

HepG2 cell lysate at 10 µg

Lane 4:

SH-SY5Y cell lysate at 10 µg

Secondary

All lanes:

Standard HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 46 kDa

Observed band size: 46 kDa

false

OI-RD Scanning - Anti-BCKDK antibody [EPR7564] (AB128935)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-BCKDK antibody [EPR7564] (AB128935)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-BCKDK antibody [EPR7564] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR7564

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase component of macronutrients metabolism. Forms a functional kinase and phosphatase pair with PPM1K, serving as a metabolic regulatory node that coordinates branched-chain amino acids (BCAAs) with glucose and lipid metabolism via two distinct phosphoprotein targets : mitochondrial BCKDHA subunit of the branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex and cytosolic ACLY, a lipogenic enzyme of Krebs cycle (PubMed : 24449431, PubMed : 29779826, PubMed : 37558654). Phosphorylates and inactivates mitochondrial BCKDH complex a multisubunit complex consisting of three multimeric components each involved in different steps of BCAA catabolism : E1 composed of BCKDHA and BCKDHB, E2 core composed of DBT monomers, and E3 composed of DLD monomers. Associates with the E2 component of BCKDH complex and phosphorylates BCKDHA on Ser-337, leading to conformational changes that interrupt substrate channeling between E1 and E2 and inactivates the BCKDH complex (PubMed : 29779826, PubMed : 37558654). Phosphorylates ACLY on Ser-455 in response to changes in cellular carbohydrate abundance such as occurs during fasting to feeding metabolic transition. Refeeding stimulates MLXIPL/ChREBP transcription factor, leading to increased BCKDK to PPM1K expression ratio, phosphorylation and activation of ACLY that ultimately results in the generation of malonyl-CoA and oxaloacetate immediate substrates of de novo lipogenesis and glucogenesis, respectively (PubMed : 29779826). Recognizes phosphosites having SxxE/D canonical motif (PubMed : 29779826).
See full target information BCKDK

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine (Cambridge, Mass.) 30:149 PubMed39267003

2024

Branched-chain amino acids supplementation induces insulin resistance and pro-inflammatory macrophage polarization via INFGR1/JAK1/STAT1 signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huaying Huang,Heye Chen,Yu Yao,Xueyong Lou

Experimental physiology 108:961-974 PubMed37139700

2023

High doses of rosuvastatin induce impaired branched-chain amino acid catabolism and lead to insulin resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Bai,Xingzhen Long,Fang Song,Baolin Chen,Changcheng Sheng,Cailin Tang,Li Li,Jiaxing Zhang,Rui Zhang,Jiquan Zhang,Jiali Li

Cells 11: PubMed36359919

2022

Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits.

Applications

Unspecified application

Species

Unspecified reactive species

Md Abu Bakkar Siddik,Caitlyn A Mullins,Alyssa Kramer,Harsh Shah,Ritchel B Gannaban,Masoud Zabet-Moghaddam,Ryan M Huebinger,Vijay K Hegde,Sheba M J MohanKumar,Puliyur S MohanKumar,Andrew C Shin

Cell metabolism 34:1749-1764.e7 PubMed36223763

2022

Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure.

Applications

Unspecified application

Species

Unspecified reactive species

Danielle Murashige,Jae Woo Jung,Michael D Neinast,Michael G Levin,Qingwei Chu,Jonathan P Lambert,Joanne F Garbincius,Boa Kim,Atsushi Hoshino,Ingrid Marti-Pamies,Kendra S McDaid,Swapnil V Shewale,Emily Flam,Steven Yang,Emilia Roberts,Li Li,Michael P Morley,Kenneth C Bedi,Matthew C Hyman,David S Frankel,Kenneth B Margulies,Richard K Assoian,John W Elrod,Cholsoon Jang,Joshua D Rabinowitz,Zoltan Arany

Cardiovascular diabetology 18:86 PubMed31277657

2019

Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure.

Applications

Unspecified application

Species

Unspecified reactive species

Golam M Uddin,Liyan Zhang,Saumya Shah,Arata Fukushima,Cory S Wagg,Keshav Gopal,Rami Al Batran,Simran Pherwani,Kim L Ho,Jamie Boisvenue,Qutuba G Karwi,Tariq Altamimi,David S Wishart,Jason R B Dyck,John R Ussher,Gavin Y Oudit,Gary D Lopaschuk

American journal of physiology. Endocrinology and metabolism 316:E73-E85 PubMed30422704

2018

Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.

Applications

Unspecified application

Species

Unspecified reactive species

Shi-Jun Yue,Juan Liu,Ai-Ting Wang,Xin-Tong Meng,Zhi-Rui Yang,Cheng Peng,Hua-Shi Guan,Chang-Yun Wang,Dan Yan

Journal of dairy science 99:1145-1160 PubMed26627857

2015

Glucose supplementation stimulates peripheral branched-chain amino acid catabolism in lactating dairy cows during essential amino acid infusions.

Applications

Unspecified application

Species

Unspecified reactive species

K Nichols,J J M Kim,M Carson,J A Metcalf,J P Cant,J Doelman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com